SFX by Ex Libris Inc.

Title:	Stem cell regulation. Bidirectional Notch signaling regulates Drosophila intestinal stem cell multipotency
Source:	Science [0036-8075] Guo, Z yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wu, William K.K. J. "Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis." Critical reviews in oncology/hematology 86.3 (2012): 251-277.
description	2.	Shi, Y. "Schistosoma japonicum: cloning, expression and characterization of a gene encoding the α5-subunit of the proteasome." Experimental Parasitology 126.4 (2010): 517-525.
description	3.	Dhawan, P. "Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation." Oncogene 30.29 (2011): 3234-3247.
description	4.	Vucic, D. "Antagonists of IAP proteins as cancer therapeutics." Cancer Letters In Press, Corrected Proof.2: 206-14.
description	5.	Cunningham, P A A. "Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study." Journal of the National Cancer Institute 90.9 (1998): 675-84.
description	6.	Kirchner, R. "Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment." Proceedings of the National Academy of Sciences of the United States of America 98.18 (2001): 10356-61.
description	7.	Kamal, A. "Apoptosis-inducing agents: a patent review (2010 - 2013)." Expert opinion on therapeutic patents 24.3 (2014): 339-54.
description	8.	Inoue, H. "Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments." Cell Death and Differentiation 21.1 (2013): 39-49.
description	9.	Sun, Ping H. "The XAF1 tumor suppressor induces autophagic cell death via upregulation of Beclin-1 and inhibition of Akt pathway." Cancer letters 310.2 (2011): 170-180.
description	10.	Zhu, Yuan X. "RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5." Blood 117.14 (2011): 3847-3857.
description	11.	Lowry, William E. "E-cadherin, a new mixer in the Yamanaka cocktail." EMBO reports 12.7 (2011): 613-614.
description	12.	Visco, V. "Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells." Journal of cellular physiology 200.1 (2004): 31-44.
description	13.	Basto D, F. "Mutation analysis of B-RAF gene in human gliomas." Acta Neuropathologica 109.2 (2005): 207-10.
description	14.	Winder, T. "Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer." Oncology reports 21.5 (2009): 1283-1287.
description	15.	Di Nicolantonio, F. "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer." Journal of clinical oncology 26.35 (2009): 5705-12.
description	16.	Lencer, Wayne I. "Patching a leaky intestine." New England Journal of Medicine, The 359.5 (2008): 526-528.
description	17.	Haluska, P. "Phase I dose escalation study of the anti-IGF-1R monoclonal antibody CP-751,871 in patients with refractory solid tumors." Journal of clinical oncology 25.18_suppl (2007): 3586-4176.
description	18.	McLeod, H. "Tumour markers of prognosis in colorectal cancer." The British journal of cancer 79.2 (1998): 191-203.
description	19.	Brabletz, T. "Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and Î²-Catenin." Cells, tissues, organs 179.1-2 (2005): 56-65.
description	20.	Condeelis, J. "Intravital imaging of cell movement in tumours." Nature reviews. Cancer 3.12 (2004): 921-30.